Neuroleptic malignant syndrome in a patient treated with lithium carbonate and haloperidol

Shanghai Archives of Psychiatry

Volumn 26, Issue 6, 2014, Pages 368-370

  Yang, Yanfen ^a   Guo, Yahui ^a   Zhang, Aiguo ^a  

^a Rongjun Kangning Psychiatric Hospital   (China)

Author keywords

China; Haloperidol; Lithium carbonate; Neuroleptic malignant syndrome

Indexed keywords

EID: 84930480558     PISSN: 10020829     EISSN: None     Source Type: Journal    
DOI: 10.11919/j.issn.1002-0829.214099     Document Type: Article

References (13)

1. World Health Organization. International Classification of Diseases, 10th Edition. 2010
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, the Fourth Edition. 1994
3. Delay J, Pichot P, Lemperiere T, Elissalde B, Peigne F. [A nonphenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychosis]. Ann Med Psychol (Paris). 1960; 118(1): 145-152. French
4. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007; 164(6): 870-876
5. Rai S, Arun P. Lithium-induced neuroleptic malignant syndrome: a case report. Hong Kong Journal of Psychiatry. 2007; 17(3): 101-102
6. Uguz F, Sonmez EÖ. Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report. Gen Hosp Psychiatry. 2013; 35(3): 327.e7-327.e8. Epub 2013 Jan 9. doi: http://dx.doi.org/10.1016/j.genhosppsych.2012.11.004
7. Gill J, Singh H, Nugent K. Acute lithium intoxication and neuroleptic malignant syndrome. Pharmacotherapy. 2003; 23(6): 811-815. doi: http://dx.doi.org/10.1592/phco.23.6.811.32179
8. Edokpolo O, Fyyaz M. Lthium toxicity and neurologic effects: probable neuroleptic malignant syndrome resulting from lithium toxicity. Case Reports in Psychiatry. 2012:271858. doi: http://dx.doi.org/10.1155/2012/271858
9. Alexander PJ, Thomas RM. Increased risk of occurrence of neuroleptic malignant syndrome on combined treatment with lithium and neuroleptic. Indian J Psychiatry. 1997; 39(3): 251-255
10. Bourgeois JA, Kahn DR. Neuroleptic malignant syndrome following administration of risperidone and lithium. J Clin Psychopharmacol. 2003; 23(3): 315-317
11. Borovicka MC, Bond LC, Gaughan KM. Ziprasidone- and lithium-induced neuroleptic malignant syndrome. Ann Pharmacother. 2006; 40(1): 139-142. Epub 2005 Dec 13. doi: http://dx.doi.org/10.1345/aph.1G470
12. Shen YC. [Psychiatry, 5th Edition]. Beijing: People's Health Publishing House; 2009. Chinese
13. Yu X, Si TM. [Prescription Guide of Psychopharmacology, 2nd Edition]. Beijing: Peking University Medical Press; 2009. Chinese